20298 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin Lactones
Compositions and methods for supporting immune health
#302METHODS OF USE FOR CAR T CELLS
#303Compositions and Methods for the Treatment of Intracranial Diseases
#304METHODS AND COMPOSITIONS FOR TREATING OBESITY AND/OR DIABETES AND FOR IDENTIFYING CANDIDATE TREATMENT AGENTS
#305Derivatives of korormicin useful as antibiotics
#306Drug delivery methods and compositions
#307Applications of Butyrolactone-I in Preparing Medicine for Preventing Neuroinflammation and/or Memory and Cognitive Disorders
#308METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS
#309LOCAL ANESTHETIC COMPRISING A TRP CHANNEL MODULATOR
#310Methods for the treatment of infections
#311COMPOUNDS FOR USE IN ANTI-CANCER IMMUNOTHERAPY
#312MUSK COMPOSITIONS AND METHODS OF USE THEREOF
#313COMBINATION THERAPIES FOR CANCER TREATMENT
#314PI3K/LYN-ACLY Signaling Inhibition
#315Methods, agents, and compositions for the treatment of acute myeloid leukemia
#316LYMPH DIRECTING PRODRUGS
#317NANO CO-DELIVERY OF QUERCETIN AND ALANTOLACTONE PROMOTES ANTI-TUMOR RESPONSE THROUGH SYNERGISTIC IMMUNOGENIC CELL DEATH FOR MICROSATELLITE-STABLE COLORECTAL CANCER
#318METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE IN COMPANION ANIMALS
#319TRANSDERMAL FORMULATIONS
#320COMPOSITION FOR TREATING HEPATITIS B, AND METHOD FOR EVALUATING REPLICATION ACTIVITY OF HEPATITIS B VIRUS
#321ENDOCANNABINOID MIMETIC AND ANTI-INFLAMMATORY COMPOUND CONTAINING COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF
#322USE OF GINKGO TERPENE LACTONE IN PREPARING DRUG FOR PREVENTING AND/OR TREATING GUILLAIN-BARRE-STROHL SYNDROME
#323BRYOSTATIN COMPOUNDS FOR ENHANCEMENT OF IMMUNOTHERAPY
#324METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
#325Ophthalmic pharmaceutical compositions and uses relating thereto
#326TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS
#327USE OF LAURUS NOBILIS EXTRACT FRACTIONS TO PROTECT AGAINST AIR POLLUTION RELATED DISEASES
#328METHODS FOR TREATING COLORECTAL CANCER
#329COMPOSITIONS AND METHODS FOR RADIOTHERAPY USING CHELATED RADIOTHERAPEUTIC AGENTS AND NON-TARGET TISSUE BLOCKADE
#330METHODS FOR TREATING TRAUMATIC BRAIN INJURY
#331Soft Chewable Pharmaceutical Products
#332PARASITICIDAL FORMULATIONS AND USE THEREOF
#333COMBINATION THERAPEUTICS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE AND OTHER DISEASES
#334ANTI-CD38 AGENTS FOR DESENSITIZATION AND TREATMENT OF ANTIBODY-MEDIATED REJECTION OF ORGAN TRANSPLANTS
#335MACROCYCLIC LACTONE ANTHELMINTICS AGAINST NEMATODES
#336METHODS OF TREATING AND PREVENTING NEURODEGENERATIVE DISEASES WITH HGF ACTIVATING COMPOUNDS
#337Compositions and methods for the treatment of AUD
#338Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
#339AQUEOUS FORMULATIONS OF WATER INSOLUBLE COX-2 INHIBITORS
#340Strategies to enhance lung cancer treatment
#341PHARMACEUTICAL DELIVERY COMPOSITIONS AND USES THEREOF
#342Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors
#343Treprostinil derivative compounds and methods of using same
#344Biophotonic compositions, methods, and kits for inhibiting and disrupting biofilms
#345METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#346PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTING, TREATING AND DIAGNOSING A NEURODEGENERATIVE DISEASE
#347Devices and methods for facilitating and controlling use of a medication
#348Compositions and methods for reactivating latent immunodeficiency virus
#349Compounds and methods of treating retinal degeneration
#350GINKGO BILOBA LEAVE EXTRACT CAPSULE AND PREPARATION METHOD THEREFOR
#351THERAPIES FOR SQUAMOUS CELL CARCINOMAS
#352FEIJOA FRUIT EXTRACT
#353STABLE CANNABINOID FORMULATIONS
#354NOVEL DOSAGE FORMS OF ROFECOXIB AND RELATED METHODS
#355Short syntheses of (−)-picrotoxinin and related compounds
#356Skin barrier composition
#357Edible Energy Composition
#358COMPOSITIONS AND METHODS FOR INDUCING APPENDAGE AND LIMB REGENERATION
#359DETERMINING DRUG COMBINATIONS, SYNERGISTIC DRUG COMBINATION AND USE THEREOF IN PANCREATIC CANCER TREATMENT
#360METHODS FOR THE TREATMENT OF MYCOBACTERIUM INFECTIONS
#361Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment of Cancer
#362Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation
#363METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS
#364Nanoparticles and nanonetworks formed therefrom
#365PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION TRIGGERED BY COVID-19
#366Covalent targeting of E3 ligases
#367LIPID PRODRUGS FOR USE IN DRUG DELIVERY
#368Enhanced Immune Response upon Treatment with Nitric Oxide
#369BIOACTIVE FORMULATION AND METHOD FOR PREPARATION THEREOF
#370STOMA POWDER INCLUDING SKIN HEALTH INGREDIENTS
#371MACROPINOCYTOSIS IN CANCER
#372COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF CORONAVIRUS INFECTIONS
#373Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same
#374PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH CTM TARGETING
#375Pharmaceutical Preparations
#376Methods for treating obesity
#377THERAPY FOR NEUROLOGICAL DISEASES/DISORDERS
#378Affinity matured CD22-specific monoclonal antibody and uses thereof
#379Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
#380RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS
#381PREPARATION OF NANOSUSPENSION COMPRISING NANOCRYSTALS OF ACTIVE PHARMACEUTICAL INGREDIENTS WITH LITTLE OR NO STABILIZING AGENTS
#382ANTIMICROBIAL COMPOSITIONS AND METHODS
#383METHODS AND COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
#384Splicing modulator antibody-drug conjugates and methods of use
#385Coordinated metabolic reprogramming in response to productive viral infections
#386Bryostatin compounds and methods of preparing the same
#387DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES
#388Reprogramming urokinase into an antibody-recruiting anticancer agent
#389Viral inhibition
#390CDC7 kinase inhibitors and uses thereof
#391Musk compositions and methods of use thereof
#392Use of an ABC transporter peptide inhibitor
#393Bryoid compositions, methods of making and use thereof
#394USE OF AVERMECTIN DERIVATIVE FOR INCREASING BIOAVAILABILITY AND EFFICACY OF MACROCYLIC LACTONES
#395QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE
#396COMPOSITIONS AND METHODS FOR DRUG DELIVERY
#397Methods and Compositions for Preventing and Treating Auditory Dysfunctions
#398Hepatitis B antiviral agents
#399Palatable antiparasitic formulations
#400Anisomeles indica extract composition for Treating or Improving Gastric Ulcer
#401Methods and compositions for treating autophagy related disease states and conditions utilizing AMPK activation
#402MRSA biofilm inhibition
#403Ginkgo diterpene lactone composition
#404Combined organ and hematopoietic cells for transplantation tolerance of grafts
#405TREATMENT OF VIRAL INFECTIONS AND VIRALLY ASSOCIATED LESIONS WITH SEQUITERPENE LACTONES
#406USE OF GINKGO BILOBA TERPENE LACTONE IN PREPARATION OF DRUGS FOR PREVENTION AND/OR TREATMENT OF TREMORS AND HEALTHCARE PRODUCTS
#407Therapeutics for Malaria
#408Carolacton and derivatives thereof for use in the treatment of cell proliferation disorders
#409INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE AGAINST PARASITE INFESTATION
#410Solid oral pharmaceutical compositions for isoxazoline compounds
#411ANTICANCER AGENT, RADIOSENSITIZER, AND FOOD COMPOSITION
#412NOVEL DOSAGE FORMS OF ROFECOXIB AND RELATED METHODS
#413Novel class of compounds for the treatment of cardiovascular disease.
#414Pharmaceutical composition and use thereof for ischemia treatment
#415Universal anti-CD22 chimeric antigen receptor engineered immune cells
#416Bile acid synthesis promoter, composition for promoting bile acid synthesis and food composition for promoting bile acid synthesis
#417Antifungal and antimicrobial uses of containing compositions
#418Devices and methods for the treatment of body surface disorders
#419CELL INTERNALIZING COMPOUNDS
#420METHODS OF IDENTIFYING MYC-DRIVEN AND LIPOGENESIS-DEPENDENT NEOPLASMS AND METHODS OF TREATING THE SAME
#421NOVEL DOSAGE FORMS OF ROFECOXIB AND RELATED METHODS
#422NOVEL KINASE FOR TREATING AND PREVENTING FUNGAL INFECTIONS, AND USE THEREOF
#423Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide
#424Edible Energy Composition
#425TARGETED NANOPARTICLES FOR DIAGNOSING, DETECTING AND TREATING CANCER
#426Glycan therapeutics and method of treating conditions associated with TMAO
#427COMPOSITIONS AND METHODS TO PROMOTE THYMIC REGENERATION
#428COMBINATIONS FOR THE TREATMENT OF CANCER
#429Splicing modulator antibody-drug conjugates and methods of use
#430Universal chimeric antigen receptor T cells specific for CD22
#431Photodynamic therapy technique for preventing damage to the fovea of the eye or another body portion of a patient
#432Methods and compositions for the treatment of pain and/or inflammation
#433COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
#434Edible Energy Composition
#435Method of treating or preventing neurodegeneration
#436SYNERGISTIC DRUG COMBINATIONS PREDICTED FROM GENOMIC FEATURES AND SINGLE-AGENT RESPONSE PROFILES
#437USE OF FLIBANSERIN IN THE TREATMENT OF OBESITY
#438Gingko diterpene lactone composition
#439METHOD FOR IMPROVING SKIN WHITENING POWER OF A SKIN WHITENING AGENT
#440Neurodegenerative Disorder Treatment Method
#441Patentiflorin A analogs as antiviral agents
#442Neprilysin inhibitors
#443Compositions and methods for pain management
#444METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#445Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
#446NEW SPIRONOLACTONE FORMULATIONS AND THEIR USE
#447Tumor microenvironment-related target TAK1 and application thereof in inhibition of tumor
#448Treatment of hearing loss
#449Methods for Detecting and Treating Idiopathic Pulmonary Fibrosis
#450Dosing regimens of PKC activators
#451Biomarkers of methotrexate-induced immune tolerance
#452Use of fatty acid oxidation inhibitors as antimicrobials
#453Quercetin-based composition for treating rhinosinusitis
#454Ocular device delivery methods and systems
#455KRILL OIL FOR SOLUBILIZING POORLY WATER-SOLUBLE DIETARY SUPPLEMENTS AND PHARMACEUTICALLY ACTIVE AGENTS
#456Compositions and methods for treating peripheral nerve disease, disorders, and injuries
#457USING COLIPASE INHIBITORS TO TREAT PANCREATITIS
#458Use of autoinducer-related pathway in inducing apoptosis and anti-infective therapy
#459METHOD OF TREATING TYPE II DIABETES AND OBESITY AND METHOD OF SCREENING A MEDICAMENT FOR THE SAME
#460Oral compositions and the preparation methods thereof
#461REDUCING IMMUNOGENICITY TO PEGLOTICASE
#462COMPOUNDS AND METHODS FOR TREATING OR PREVENTING FIBROSIS
#463COMPOSITIONS AND METHODS FOR TREATING SKIN AND NEUROPATHIC CONDITIONS AND DISORDERS
#464Derivatives of korormicin useful as antibiotics
#465Edible Energy Composition
#466Methods and compositions for increasing the potency of antifungal agents
#467MUSK COMPOSITIONS AND METHODS OF USE THEREOF
#468METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 AND FATTY ACID METABOLISM INHIBITORS
#469Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
#470Methods for inducing synaptogenesis with synaptic growth factor activating compounds
#471GLUCOSE CONJUGATES OF TRIPTOLIDE, ANALOGS AND USES THEREOF
#472PRESERVATION OF THE NEUROMUSCULAR JUNCTION AFTER TRAUMATIC NERVE INJURY
#473ENHANCED ANTIVIRULENT FOR ANTIBIOTIC-RESISTANT BACTERIA
#474THIENOISOQUINOLINES AND THEIR DERIVATIVES FOR TARGETING TUBULIN, CH-TOG, AURORA A KINASE, TPX2, CDK5RAP2 AND/OR ASPM
#475METHODS OF MODULATING PROTEIN EXOCYTOSIS AND USES OF SAME IN THERAPY
#476Extended release microparticles comprising drug, and preparation method therefor
#477Pharmaceutical composition for preventing and treating alpha herpes virus infection, containing, as active ingredient, extract or fraction thereof
#478USE OF SENOLYTIC AGENTS TO ELIMINATE PERSISTENT HIV RESERVOIRS
#479IDH1 INHIBITORS FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS
#480Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation
#481Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#482PIM kinase inhibitors in combination with autophagy inhibitors for treatment of cancers
#483Compounds and methods of treating retinal degeneration
#484Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
#485MEDICINAL AMBROSIA PLANT EXTRACTS
#486BILE ACID SYNTHESIS PROMOTER, COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS AND FOOD COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS
#487Skin barrier composition
#488Ophthalmic pharmaceutical compositions and uses relating thereto
#489INHIBITOR OF TRPM-4 ION CHANNEL FOR TREATING OR PREVENTING NEURODEGENERATION
#490Transplantation Therapies
#491Transplantation Therapies
#492Hepatitis B antiviral agents
#493Apparatus for a mass production of monodisperse biodegradeable polymer-based microspheres and a multi-channel forming device incorporatable therein
#494SPLICEOSOME MUTATIONS AND USES THEREOF
#495COMPOSITIONS OF SCHISANDRA EXTRACTS AND METHODS THEREOF
#496Compounds and methods for inducing chondrogenesis
#497Use of secoisolariciresinol diglucosides (SDGS) and related compounds for protection against radiation and chemical damage
#498PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF
#499COMPOSITION FOR TREATING BENIGN PROSTATE HYPERPLASIA AND FUNCTIONAL HEALTH FOOD COMPRISING AUCKLANDIAE RADIX EXTRACT AND COSTUNOLIDE AS ACTIVE INGREDIENTS
#500Use of a composition comprising 7-hydroxymatairesinol
#501Food supplements for use in the prophylaxis and treatment of migraine
#502Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
#503ANTIMICROBIAL FUSION PEPTIDES
#504Hypotonic microbicidal formulations and methods of use
#505Modulation of Bacterial Quorum Sensing With Synthetic Ligands
#506Methods for treating obesity
#507ENHANCED IMMUNE RESPONSE UPON TREATMENT WITH NITRIC OXIDE
#508Glycan therapeutics and related methods thereof
#509Glycan therapeutics and related methods thereof
#510Methods and compositions for the inhibition of PIN1
#511Methods, agents, and compositions for the treatment of acute myeloid leukemia
#512Combination HIV therapeutic
#513Acylated glucagon analogue
#514Sulfonamide analogues of galiellalactone
#515METHODS TO TREAT FIBROSIS, NASH, AND NAFLD
#516Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
#517T REGULATORY CELLS AND USES THEREOF
#518Methods and Systems for Modulating Hormones and Related Methods, Agents and Compositions
#519Edible Energy Composition
#520Pharmaceutical compounds and uses thereof
#521CHEMICAL ENTITIES THAT KILL SENESCENT CELLS FOR USE IN TREATING AGE-RELATED DISEASE
#522Methods and compositions for preventing and treating auditory dysfunctions
#523Glutarate compounds for treating ischemia-reperfusion injuries
#524USE OF N-BUTYLIDENEPHTHALIDE IN DOPAMINERGIC PROGENITOR CELL TRANSPLANTATION
#525Treprostinil derivative compounds and methods of using same
#526Targeted nanocarriers for the administration of immunosuppressive agents
#527USE OF TRICYCLIC SESQUITERPENE LACTONES IN THE TREATMENT OF OBESITY AND RELATED DISEASES AND NON-THERAPEUTIC TREATABLE CONDITIONS
#528Compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema
#529PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for treatment of cancers
#530COMPOSITIONS AND METHODS OF IMPROVED WOUND HEALING
#531METHODS OF TREATING LUNG CANCER WITH A PD-1 AXIS BINDING ANTAGONIST, A PLATINUM AGENT, AND A TOPOISOMERASE II INHIBITOR
#532Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
#533Andrographolide derivatives and method of using the same for treatment or prevention of fibrosis
#534Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof
#535Method for treating an allergic disease
#536Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds
#537Di-substituted maleic amide linker for antibody drug conjugating and preparation method and use thereof
#538Combinations to treat cancer
#539Parthenolide and its derivative for use in the treatment of axonal damage
#540Non-aromatic difluoro analogues of resorcylic acid lactones
#541Oral pharmaceutical formulation for weight loss, diabetes and related disorders
#542Dosing regimens of PKC activators
#543Reprogramming urokinase into an antibody-recruiting anticancer agent
#544SYNTHESIS OF RESORCYLIC ACID LACTONES USEFUL AS THERAPEUTIC AGENTS
#545Cell internalizing compounds
#546TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED HUMAN ALPHA-L-IDURONIDASE (IDUA)
#547Combined organ and hematopoietic cells for transplantation tolerance of grafts
#548USE OF OVATODIOLIDE FOR PREPARING A COMPOSITION FOR INHIBITING PROTEIN SYNTHESIS OF GASTRIC HELICOBACTER PYPORI
#549Bridged bicycloalkyl-substituted aminothiazoles and their methods of use
#550Methods for Treating Bone-Related Disorders
#551METHODS AND COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE
#552Pharmaceutical composition for preventing or treating cancer
#553Compositions and methods for reactivating latent immunodeficiency virus
#554TREATMENT OF KRABBE DISEASE WITH UMBILICAL CORD BLOOD TRANSPLANTION (UCBT) AND INCREASED GALACTOCEREBROSIDASE (GALC) EXPRESSION
#555Combined organ and hematopoietic cells for transplantation tolerance of grafts
#556AGENTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH EXTRACELLULAR MATRIX TURNOVER
#557Composition and method for improving sleep duration and quality
#558Preservation of immune response during chemotherapy regimens
#559Cdc7 kinase inhibitors and uses thereof
#560Methods of treating skin with aromatic skin-active ingredients
#561Endoplasmic reticulum-targeting nanovehicles and methods for use thereof
#562NOVEL ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
#563Edible energy composition
#564Combined organ and hematopoietic cells for transplantation tolerance of grafts
#565Methods of cancer treatment
#566Bryostatin compounds and methods of preparing the same
#567Combination therapy including an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
#568COMPOSITIONS AND METHODS FOR TREATING HIV-1 LATENCY
#569PHARMACEUTICAL COMPOSITIONS FOR TREATING EBOLA VIRUS DISEASE
#570Edible energy composition
#571Use of Flibanserin in the treatment of obesity
#572Agents directed against a cis RGMa/neogenin interaction or lipid rafts and use of the same in methods of treatment
#573GENE TRANSFER COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES
#574USE OF ARTEMISININ FOR TREATING TUMORS INDUCED BY ONCOGENIC VIRUSES AND FOR TREATING VIRAL INFECTIONS
#575Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#576Enhanced Gene Delivery to Natural Killer Cells, Hematopoietic Stem Cells and Macrophages
#577Neprilysin inhibitors
#578Methods of use for CAR T cells
#579SELF-EMULSIFYING LIPID COMPOSITIONS
#580Ophthalmic drug delivery method
#581Extracts of , methods for preparation and use thereof
#582Methods of treating disorders with glycosylation defective proteins
#583Methods of use for CAR T cells
#584Controlled drug release liposome compositions and methods thereof
#585PHARMACEUTICAL PREPARATIONS
#586Biophotonic compositions, methods, and kits for inhibiting and disrupting biofilms
#587Pharmaceutical Composition for Preventing and Treating Alpha Herpes Virus Infection, Containing, As Active Ingredient, Elaeocarpus Sylvestris Extract or Fraction Thereof
#588METHODS OF STIMULATING CELLULAR GROWTH, SYNAPTIC REMODELING AND CONSOLIDATION OF LONG TERM MEMORY
#589PHARMACOLOGICAL TREATMENT OF COGNITIVE IMPAIRMENT
#590METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS
#591Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
#592Ketone bodies and ketone body esters as blood lipid lowering agents
#593Glutarate compounds for treating ischemia-reperfusion injuries
#594Soft chewable pharmaceutical products
#595Composition for combating the signs of ageing of the skin and hair and nails
#596Bryoid compositions, methods of making and use thereof
#597Combined organ and hematopoietic cells for transplantation tolerance of grafts
#598Combined organ and hematopoietic cells for transplantation tolerance of grafts
#599Immunomodulator
#600Dehydroleucodine derivatives and uses thereof